370
Participants
Start Date
October 26, 2023
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2032
Trastuzumab deruxtecan
Experimental drug. Provided in 100mg vials. IV infusion.
Docetaxel
Active comparator. IV infusion.
Paclitaxel
Active comparator. IV infusion.
Carboplatin
Active comparator. IV infusion.
Trastuzumab
Active comparator. IV infusion.
Pertuzumab
Active comparator. IV infusion.
Ribociclib
Experimental drug. Tablets.
Letrozole
Experimental drug. Tablets.
Epirubicin
Active comparator. IV infusion.
Cyclophosphamide
Active comparator. IV infusion.
NOT_YET_RECRUITING
Sankt Gorans Hospital, Stockholm
NOT_YET_RECRUITING
Stockholm Southern Hospital, Stockholm
RECRUITING
Karolinska University Hospital, Stockholm
NOT_YET_RECRUITING
Skåne University Hospital, Malmo
NOT_YET_RECRUITING
Örebro University Hospital, Örebro
NOT_YET_RECRUITING
Uppsala University Hospital, Uppsala
NOT_YET_RECRUITING
Norrlands University Hospital, Umeå
Karolinska University Hospital
OTHER